S-4 - Vallon Pharmaceuticals, Inc. (0001824293) (Filer)

1 min to read

S-4 – Vallon Pharmaceuticals, Inc. (0001824293) (Filer)

Filed: 2022-12-23 AccNo: 0001628280-22-032519 Size: 25 MB
Source: S-4 – Vallon Pharmaceuticals, Inc. (0001824293) (Filer)

Tags: SEC

e.GO's Registration Statement on Form F-4 in Connection With Its … – Business Wire

e.GO's Registration Statement on Form F-4 in Connection With Its ... Business Wire Source: e.GO's Registration Statement on Form F-4 in...
Athena Consumer Acquisition Corp. Announces Extension of … – WDRB

Athena Consumer Acquisition Corp. Announces Extension of ... WDRB Source: Athena Consumer Acquisition Corp. Announces Extension of ... - WDRB
Demandbase Announces New Executive Hires with Industry … – PR Newswire

Demandbase Announces New Executive Hires with Industry ... PR Newswire Source: Demandbase Announces New Executive Hires with Industry ... - PR...
26 Capital Acquisition Corp. Announces Liquidation – PR Newswire

26 Capital Acquisition Corp. Announces Liquidation PR Newswire Source: 26 Capital Acquisition Corp. Announces Liquidation - PR Newswire
Dissecting the Direct Listing Die-Out

When weighing options for going public, savvy entrepreneurs sometimes consider using the Direct Listing method instead of opting for a...